TradingKey

關於 AtriCure Inc 公司

AtriCure, Inc. 提供治療心房顫動 (Afib)、左心耳 (LAA) 管理和術後疼痛管理的技術。該公司的心臟消融和左心耳管理 (LAAM) 產品供醫生在開胸和微創外科手術中使用。其疼痛管理解決方案供醫生在心胸外科或胸外科手術過程中凍結神經。該公司的開放式和微創消融產品包括 Isolator Synergy 夾鉗和多功能筆和線性消融設備。其開放式消融產品包括 cryoICE 冷凍消融系統。其微創消融產品包括採用 VisiTrax 技術的 EPi-Sense 引導凝血系統。其附屬物管理產品包括 AtriClip 系統。Isolator Synergy 消融系統夾鉗是一次性使用的射頻 (RF) 產品，其鉗口以平行方式閉合。

公司簡介

公司代碼ATRC

公司名稱AtriCure Inc

上市日期Aug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

員工數量1300

證券類型Ordinary Share

年結日Aug 05

公司地址7555 Innovation Way

城市MASON

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編45040

電話15137554100

網址https://www.atricure.com

公司代碼ATRC

上市日期Aug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Ms. Regina E. (Reggie) Groves

Independent Director

36.17K

+17.56%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

+18.64%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+32.18%

Mr. Shlomo Nachman

Independent Director

18.51K

+41.20%

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

地區USD

名稱

營收

佔比

United States

101.15M

81.82%

Europe

14.20M

11.49%

Asia

6.78M

5.49%

Other international

1.49M

1.20%

業務

地區

業務USD

名稱

營收

佔比

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

股東統計

更新時間: 5月20日週二

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

持股股東

佔比

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

股東類型

持股股東

佔比

Investment Advisor

56.65%

Investment Advisor/Hedge Fund

33.71%

Hedge Fund

10.66%

Individual Investor

3.55%

Research Firm

1.93%

Pension Fund

0.75%

Bank and Trust

0.50%

Sovereign Wealth Fund

0.23%

Family Office

0.07%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

531

53.52M

108.11%

-4.10M

2025Q1

544

53.44M

107.95%

-4.07M

2024Q4

526

50.00M

102.31%

-11.07M

2024Q3

522

53.78M

110.47%

-8.64M

2024Q2

511

54.11M

111.85%

-4.03M

2024Q1

517

53.02M

109.65%

-1.47M

2023Q4

515

50.20M

105.93%

-1.70M

2023Q3

504

48.87M

103.22%

-3.82M

2023Q2

499

48.88M

103.48%

-3.46M

2023Q1

503

48.62M

102.63%

-1.48M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

4.70M

9.5%

+61.17K

+1.32%

Mar 31, 2025

AllianceBernstein L.P.

3.68M

7.43%

-158.60K

-4.14%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.57M

7.21%

-92.41K

-2.52%

Mar 31, 2025

Hood River Capital Management LLC

3.00M

6.06%

+75.48K

+2.58%

Mar 31, 2025

Macquarie Investment Management

2.44M

4.92%

+61.60K

+2.59%

Mar 31, 2025

Champlain Investment Partners, LLC

2.14M

4.32%

-390.65K

-15.45%

Mar 31, 2025

Two Sigma Investments, LP

1.33M

2.68%

+75.83K

+6.06%

Mar 31, 2025

First Light Asset Management, LLC

1.31M

2.66%

-654.50K

-33.24%

Mar 31, 2025

State Street Global Advisors (US)

1.28M

2.58%

-68.53K

-5.09%

Mar 31, 2025

UBS Asset Management (Switzerland)

1.26M

2.54%

+537.08K

+74.31%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

SPDR S&P Health Care Equipment ETF

1.81%

Harbor Human Capital Factor US Small Cap ETF

0.76%

NYLI Healthy Hearts ETF

0.47%

First Trust Small Cap Growth AlphaDEX Fund

0.45%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Amplify Etho Climate Leadership U.S. ETF

0.3%

JPMorgan Fundamental Data Science Small Core ETF

0.26%

Franklin US Small Cap Multifactor Index ETF

0.25%

First Trust Small Cap Core Alphadex Fund

0.24%

iShares U.S. Medical Devices ETF

0.18%

SPDR S&P Health Care Equipment ETF

佔比1.81%

Harbor Human Capital Factor US Small Cap ETF

佔比0.76%

NYLI Healthy Hearts ETF

佔比0.47%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.45%

Invesco NASDAQ Future Gen 200 ETF

佔比0.43%

Amplify Etho Climate Leadership U.S. ETF

佔比0.3%

JPMorgan Fundamental Data Science Small Core ETF

佔比0.26%

Franklin US Small Cap Multifactor Index ETF

佔比0.25%

First Trust Small Cap Core Alphadex Fund

佔比0.24%

iShares U.S. Medical Devices ETF

佔比0.18%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

AtriCure Inc

34.410USD

AtriCure Inc

34.410

概覽

公司

財務